医学
非酒精性脂肪肝
疾病
内科学
糖尿病
肥胖
慢性肝病
儿科
2型糖尿病
脂肪肝
重症监护医学
内分泌学
肝硬化
标识
DOI:10.1016/j.cld.2022.05.001
摘要
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. Although environmental factors are major contributors to early onset, children have both shared and unique genetic risk alleles as compared with adults with NAFLD. Treatment relies on reducing environmental risk factors, but many children have persistent diseases. No medications are approved specifically for the treatment of NAFLD, but some anti-obesity or diabetes treatments may be beneficial. Pediatric NAFLD increases the risk of diabetes and other cardiovascular risk factors. Long-term prospective studies are needed to determine the long-term risk of hepatic and non-hepatic morbidity and mortality in adulthood.
科研通智能强力驱动
Strongly Powered by AbleSci AI